Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Breyer

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Harvard Law Review|December 13, 1978
Analyzing regulatory failure: mismatches, less restrictive alternatives, and reformS Breyer
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|February 9, 1988
[Interleukin 1 (IL-1). A mediator in inflammation]S Breyer
Science (New York, N.Y.)|May 9, 1998
The interdependence of science and lawS Breyer
Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[Biochemistry, molecular mechanism of action and biological effects of endotoxin]H Burgmann, S Breyer
European Journal of Medicinal Chemistry|February 6, 2010
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazonesK Effenberger, S Breyer, R Schobert
Fortschritte Der Medizin|September 10, 1988
[Preventive use of antibiotics in colorectal interventions. Short-term versus one-shot prevention--a multicenter study]A Tuchmann, S Breyer, U Ganzinger
Wiener Medizinische Wochenschrift (1946)|June 30, 1980
[Pharmacokinetics, tolerance and therapeutic effect of trimethoprim-sulfametrol-infusions (author's transl)]S Breyer, W Graninger, G Hitzenberger
Drugs Under Experimental and Clinical Research|January 1, 1987
In vitro evaluation of teicoplanin and other antimicrobials against streptococci group D bacteriaS Breyer, A Georgopoulos, W Graninger
International Journal of Clinical Pharmacology and Therapeutics|June 19, 2010
New doxorubicin N-acyl hydrazones with improved efficacy and cell line specificity show modes of action different from the parent drugK Effenberger, S Breyer, M Ocker, et al.
The Clinical Investigator|November 1, 1994
Intravenous teicoplanin does not prevent Clostridium difficile associated diarrheaC Wenisch, E Etzersdorfer, S Breyer, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Harvard Law Review|December 13, 1978
Analyzing regulatory failure: mismatches, less restrictive alternatives, and reformS Breyer
Schweizerische Rundschau Fur Medizin Praxis = Revue Suisse De Medecine Praxis|February 9, 1988
[Interleukin 1 (IL-1). A mediator in inflammation]S Breyer
Science (New York, N.Y.)|May 9, 1998
The interdependence of science and lawS Breyer
Wiener Medizinische Wochenschrift (1946)|January 1, 1995
[Biochemistry, molecular mechanism of action and biological effects of endotoxin]H Burgmann, S Breyer
European Journal of Medicinal Chemistry|February 6, 2010
Modulation of doxorubicin activity in cancer cells by conjugation with fatty acyl and terpenyl hydrazonesK Effenberger, S Breyer, R Schobert
Fortschritte Der Medizin|September 10, 1988
[Preventive use of antibiotics in colorectal interventions. Short-term versus one-shot prevention--a multicenter study]A Tuchmann, S Breyer, U Ganzinger
Wiener Medizinische Wochenschrift (1946)|June 30, 1980
[Pharmacokinetics, tolerance and therapeutic effect of trimethoprim-sulfametrol-infusions (author's transl)]S Breyer, W Graninger, G Hitzenberger
Drugs Under Experimental and Clinical Research|January 1, 1987
In vitro evaluation of teicoplanin and other antimicrobials against streptococci group D bacteriaS Breyer, A Georgopoulos, W Graninger
International Journal of Clinical Pharmacology and Therapeutics|June 19, 2010
New doxorubicin N-acyl hydrazones with improved efficacy and cell line specificity show modes of action different from the parent drugK Effenberger, S Breyer, M Ocker, et al.
The Clinical Investigator|November 1, 1994
Intravenous teicoplanin does not prevent Clostridium difficile associated diarrheaC Wenisch, E Etzersdorfer, S Breyer, et al.
Pageof 5